vs

Side-by-side financial comparison of La Rosa Holdings Corp. (LRHC) and Arcus Biosciences, Inc. (RCUS). Click either name above to swap in a different company.

La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $11.0M, roughly 1.8× Arcus Biosciences, Inc.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -963.6%, a 936.3% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -52.2%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs 4.9%).

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

LRHC vs RCUS — Head-to-Head

Bigger by revenue
LRHC
LRHC
1.8× larger
LRHC
$20.2M
$11.0M
RCUS
Growing faster (revenue YoY)
LRHC
LRHC
+55.4% gap
LRHC
3.2%
-52.2%
RCUS
Higher net margin
LRHC
LRHC
936.3% more per $
LRHC
-27.4%
-963.6%
RCUS
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
4.9%
RCUS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
LRHC
LRHC
RCUS
RCUS
Revenue
$20.2M
$11.0M
Net Profit
$-5.5M
$-106.0M
Gross Margin
8.4%
Operating Margin
-24.7%
-1036.4%
Net Margin
-27.4%
-963.6%
Revenue YoY
3.2%
-52.2%
Net Profit YoY
-125.7%
-12.8%
EPS (diluted)
$-5.44
$-0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LRHC
LRHC
RCUS
RCUS
Q4 25
$11.0M
Q3 25
$20.2M
$6.0M
Q2 25
$23.2M
$8.0M
Q1 25
$17.5M
$8.0M
Q4 24
$17.7M
$23.0M
Q3 24
$19.6M
$7.0M
Q2 24
$19.1M
$11.0M
Q1 24
$13.1M
$10.0M
Net Profit
LRHC
LRHC
RCUS
RCUS
Q4 25
$-106.0M
Q3 25
$-5.5M
$-135.0M
Q2 25
$78.4M
$0
Q1 25
$-95.7M
$-112.0M
Q4 24
$-5.1M
$-94.0M
Q3 24
$-2.5M
$-92.0M
Q2 24
$-2.3M
$-93.0M
Q1 24
$-4.6M
$-4.0M
Gross Margin
LRHC
LRHC
RCUS
RCUS
Q4 25
Q3 25
8.4%
Q2 25
8.0%
Q1 25
8.8%
Q4 24
8.9%
Q3 24
8.3%
Q2 24
8.3%
Q1 24
8.9%
Operating Margin
LRHC
LRHC
RCUS
RCUS
Q4 25
-1036.4%
Q3 25
-24.7%
-2366.7%
Q2 25
-10.6%
-100.0%
Q1 25
-26.7%
-1525.0%
Q4 24
-17.1%
-447.8%
Q3 24
-8.9%
-1500.0%
Q2 24
-9.7%
-963.6%
Q1 24
-35.0%
-160.0%
Net Margin
LRHC
LRHC
RCUS
RCUS
Q4 25
-963.6%
Q3 25
-27.4%
-2250.0%
Q2 25
337.8%
Q1 25
-546.5%
-1400.0%
Q4 24
-28.7%
-408.7%
Q3 24
-12.5%
-1314.3%
Q2 24
-12.2%
-845.5%
Q1 24
-35.1%
-40.0%
EPS (diluted)
LRHC
LRHC
RCUS
RCUS
Q4 25
$-0.88
Q3 25
$-5.44
$-1.27
Q2 25
$15.25
$0.00
Q1 25
$-5.86
$-1.14
Q4 24
$28.54
$-1.07
Q3 24
$-16.49
$-1.00
Q2 24
$-12.49
$-1.02
Q1 24
$-0.35
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LRHC
LRHC
RCUS
RCUS
Cash + ST InvestmentsLiquidity on hand
$4.0M
$222.0M
Total DebtLower is stronger
$642.8K
$99.0M
Stockholders' EquityBook value
$1.6M
$631.0M
Total Assets
$21.7M
$1.1B
Debt / EquityLower = less leverage
0.41×
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LRHC
LRHC
RCUS
RCUS
Q4 25
$222.0M
Q3 25
$4.0M
$238.0M
Q2 25
$5.1M
$248.0M
Q1 25
$2.9M
$192.0M
Q4 24
$1.4M
$150.0M
Q3 24
$1.8M
$201.0M
Q2 24
$1.6M
$156.0M
Q1 24
$1.1M
$185.0M
Total Debt
LRHC
LRHC
RCUS
RCUS
Q4 25
$99.0M
Q3 25
$642.8K
$98.0M
Q2 25
$644.3K
$97.0M
Q1 25
$645.9K
$48.0M
Q4 24
$647.6K
$48.0M
Q3 24
$649.2K
$47.0M
Q2 24
$650.8K
Q1 24
$652.4K
Stockholders' Equity
LRHC
LRHC
RCUS
RCUS
Q4 25
$631.0M
Q3 25
$1.6M
$436.0M
Q2 25
$3.4M
$549.0M
Q1 25
$-87.5M
$531.0M
Q4 24
$2.6M
$485.0M
Q3 24
$5.0M
$565.0M
Q2 24
$4.7M
$635.0M
Q1 24
$5.6M
$707.0M
Total Assets
LRHC
LRHC
RCUS
RCUS
Q4 25
$1.1B
Q3 25
$21.7M
$974.0M
Q2 25
$22.9M
$1.1B
Q1 25
$21.0M
$1.2B
Q4 24
$19.4M
$1.1B
Q3 24
$19.7M
$1.3B
Q2 24
$18.7M
$1.2B
Q1 24
$16.3M
$1.3B
Debt / Equity
LRHC
LRHC
RCUS
RCUS
Q4 25
0.16×
Q3 25
0.41×
0.22×
Q2 25
0.19×
0.18×
Q1 25
0.09×
Q4 24
0.25×
0.10×
Q3 24
0.13×
0.08×
Q2 24
0.14×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LRHC
LRHC
RCUS
RCUS
Operating Cash FlowLast quarter
$-1.3M
$-120.0M
Free Cash FlowOCF − Capex
$-121.0M
FCF MarginFCF / Revenue
-1100.0%
Capex IntensityCapex / Revenue
9.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LRHC
LRHC
RCUS
RCUS
Q4 25
$-120.0M
Q3 25
$-1.3M
$-97.0M
Q2 25
$-1.4M
$-133.0M
Q1 25
$-3.5M
$-132.0M
Q4 24
$-1.1M
$-100.0M
Q3 24
$-591.6K
$26.0M
Q2 24
$-803.1K
$-94.0M
Q1 24
$-538.3K
$-2.0M
Free Cash Flow
LRHC
LRHC
RCUS
RCUS
Q4 25
$-121.0M
Q3 25
Q2 25
Q1 25
$-133.0M
Q4 24
$-101.0M
Q3 24
$25.0M
Q2 24
Q1 24
$-6.0M
FCF Margin
LRHC
LRHC
RCUS
RCUS
Q4 25
-1100.0%
Q3 25
Q2 25
Q1 25
-1662.5%
Q4 24
-439.1%
Q3 24
357.1%
Q2 24
Q1 24
-60.0%
Capex Intensity
LRHC
LRHC
RCUS
RCUS
Q4 25
9.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
12.5%
Q4 24
4.3%
Q3 24
14.3%
Q2 24
0.0%
Q1 24
40.0%
Cash Conversion
LRHC
LRHC
RCUS
RCUS
Q4 25
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

RCUS
RCUS

Other$5.0M45%
Other Collaboration Revenue$4.0M36%
Access Rights And Option Continuation Periods$2.0M18%

Related Comparisons